Bausch Health Companies Inc. (TSX:BHC)
Canada · Delayed Price · Currency is CAD 11.87
-0.54 (-4.35%)
Oct 30, 2026, 1:12 PM EDT
Bausch Health Companies Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,113 | 10,266 | 9,625 | 8,757 | 8,124 | 8,434 |
Revenue Growth | 10.81% | 6.66% | 9.91% | 7.79% | -3.68% | 5.07% |
Gross Profit Gross Profit Growth | 8,070 | 7,253 | 6,843 | 6,198 | 5,760 | 6,040 |
Operating Income Operating Income Growth | 3,021 | 2,192 | 1,874 | 1,621 | 1,484 | 1,708 |
Net Income Net Income Growth | -841 | 157 | -46 | -592 | -225 | -948 |
Earnings Per Share EPS Growth | -2.25 | 0.42 | -0.13 | -1.62 | -0.62 | -2.64 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Salix Salix Growth | 2,921 | 2,578 | 2,333 | 2,250 | 2,090 | 2,074 |
International Rx International Rx Growth | 1,195 | 1,132 | 1,111 | 1,071 | 988 | 1,166 |
Solta Medical Solta Medical Growth | 649 | 518 | 440 | 347 | 300 | 308 |
Diversified Products Diversified Products Growth | 930 | 937 | 950 | 943 | 978 | 1,121 |
Bausch + Lomb Bausch + Lomb Growth | 5,418 | 5,101 | 4,791 | 4,146 | 3,768 | 3,765 |
Revenue (Total) Revenue (Total) Growth | 13,218 | 10,266 | 9,625 | 8,757 | 8,124 | 6,673 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 2,485 | 1,309 | 1,181 | 947 | 564 | 582 |
Total Debt Total Debt Growth | 20,715 | 21,079 | 21,839 | 22,597 | 21,000 | 22,918 |
Net Cash (Debt) Net Cash Growth | -18,230 | -19,770 | -20,658 | -21,650 | -20,436 | -22,336 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -48.77 | -52.72 | -56.14 | -59.33 | -56.45 | -62.23 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 2,209 | 1,400 | 1,597 | 1,032 | -728 | 1,426 |
Capital Expenditures CapEx Growth | -344 | -397 | -337 | -215 | -218 | -269 |
Free Cash Flow Free Cash Flow Growth | 1,865 | 1,003 | 1,260 | 817 | -946 | 1,157 |
Free Cash Flow Growth | 70.32% | -20.40% | 54.22% | - | - | 43.02% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 72.62% | 70.65% | 71.10% | 70.78% | 70.90% | 71.61% |
Operating Margin | 27.18% | 21.35% | 19.47% | 18.51% | 18.27% | 20.25% |
Pretax Margin | -3.18% | 3.57% | 1.74% | -4.45% | -1.59% | -12.14% |
Profit Margin | -7.57% | 1.53% | -0.48% | -6.76% | -2.77% | -11.24% |
FCF Margin | 16.78% | 9.77% | 13.09% | 9.33% | -11.64% | 13.72% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 16.40 | - | - | - | - |
P/FCF Ratio | 1.76 | 2.57 | 2.35 | 3.59 | - | 8.57 |
PS Ratio | 0.30 | 0.25 | 0.31 | 0.33 | 0.28 | 1.18 |